EANS-Adhoc: +++ Reminder +++ LifeWatch AG to report on positive Q2 2010 results on Thursday, July 29, 2010

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

6-month report/LifeWatch AG

19.07.2010

- 07:00 a.m. CEST: Press release/Letter to Shareholders;
- 10:00 a.m. CEST: Analyst/Media Conference; Conference Call/Webcast;

Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss
Exchange: LIFE) will report on its positive second quarter 2010
results on Thursday, July 29, 2010, by issuing a Press Release and
Letter to Shareholders at 07:00 a.m. CEST and hosting an
English-speaking Analyst and Media Conference at 10:00 a.m. CEST at
Zunfthaus zur Saffran, Limmatquai 54, 8001 Zürich/Switzerland. Please
register for the live Zürich conference by email to
lifewatch@sensus.ch. The conference is also accessible as a
conference call/webcast at:

+ 41 (0)91 610 56 00 (Europe);
+ 44 (0)207 107 06 11 (UK);
+ 1(1)866 291 41 66 (USA - Toll-free);

http://www.irlifewatch.com

About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on
SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare
technology and solution company, specializing in advanced telehealth
systems and wireless remote patient monitoring services. LifeWatch
services cater to individuals, ranging from high-risk and chronically
ill patients, to consumers of health and wellness products. LifeWatch
has subsidiaries in the United States, the Netherlands, Japan, the
United Kingdom, Switzerland and Israel. LifeWatch AG is the parent
company of LifeWatch Services Inc., a leading US-based cardiac
monitoring service provider, and manufacturer of telecardiology
products. LifeWatch is also introducing a new program for Home
SleepTesting of Obstructive Sleep Apnea (OSA) patients under the
brand name NiteWatch. For additional information, please visit
www.lifewatch.com.

Sign-up for customized E-mail alerts and documentation requests is
available at http://production.investis.com/lifewatch/alert-service/

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: LifeWatch AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Woo Kim, Senior Vice President of Strategy and Business Development, LifeWatch

Tel +1 847 813 4299 | Fax +1 847 813 24 48 | Email wkim@lifewatch.com

Sensus Investor and Public Relations, Zürich:

Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
Berlin / free trade
SIX Swiss Exchange / Main Standard